Kevin B. Alton
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 20
- Inflammatory mediators and NSAID effects 8
- Antibiotics Pharmacokinetics and Efficacy 7
- Pharmaceutical Science top 2%
- Analytical Chemistry top 2%
- Analytical Methods in Pharmaceuticals 7
- Spectroscopy top 2%
- Analytical Chemistry and Chromatography 13
- Mass Spectrometry Techniques and Applications 6
- Cancer Research top 5%
-
- Metabolomics and Mass Spectrometry Studies 7
-
- Drug Transport and Resistance Mechanisms 7
- Co-authors
- Swapan K. ChowdhuryJames E. PatrickPaul StatkevichHarry R. DavisMark WirthTeddy KosoglouEdmund J. SybertzMargaret van Heek
- Journals
- Analytical Chemistry (4 papers)Advanced Drug Delivery Reviews (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Kevin B. Alton
48 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 124
- Pharmacology 501
- Pharmaceutical Science 203
- Analytical Chemistry 243
- Spectroscopy 386
- Cancer Research 324
Countries citing papers authored by Kevin B. Alton
This map shows the geographic impact of Kevin B. Alton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin B. Alton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin B. Alton more than expected).
Fields of papers citing papers by Kevin B. Alton
This network shows the impact of papers produced by Kevin B. Alton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin B. Alton. The network helps show where Kevin B. Alton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kevin B. Alton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 43 | |
| 2 | 2011 | 208 | |
| 3 | 2010 | 8 | |
| 4 | 2010 | 53 | |
| 5 | 2010 | 44 | |
| 6 | 2009 | 50 | |
| 7 | 2009 | 34 | |
| 8 | 2007 | 28 | |
| 9 | 2007 | 19 | |
| 10 | 2005 | 24 | |
| 11 | 2005 | 364 | |
| 12 | 2004 | 139 | |
| 13 | 2004 | 108 | |
| 14 | 2003 | 12 | |
| 15 | 2002 | 2 | |
| 16 | 2001 | 53 | |
| 17 | 2000 | 265 | |
| 18 | Pharmacokinetics and pharmacodynamics of dilevalol alone and with cimetidine | 1989 | 4 |
| 19 | 1988 | 9 | |
| 20 | 1975 | 3 |
About Kevin B. Alton
Kevin B. Alton is a scholar working on Pharmacology, Spectroscopy and Pharmacology, having authored 49 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (20 papers), Analytical Chemistry and Chromatography (13 papers), Inflammatory mediators and NSAID effects (8 papers), Metabolomics and Mass Spectrometry Studies (7 papers), Analytical Methods in Pharmaceuticals (7 papers), Drug Transport and Resistance Mechanisms (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Mass Spectrometry Techniques and Applications (6 papers). The work is most often cited by research in Pharmacology (501 citations), Pharmaceutical Science (203 citations) and Analytical Chemistry (243 citations). Kevin B. Alton has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Swapan K. Chowdhury, James E. Patrick, Paul Statkevich, Harry R. Davis, Mark Wirth, Teddy Kosoglou, Edmund J. Sybertz, Margaret van Heek, Douglas S. Compton and Arthur Bergman. Their work appears in journals such as Analytical Chemistry, Advanced Drug Delivery Reviews and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.